NOR-1 在细针穿刺细胞块中区分腺泡细胞癌与其类似病变
该研究在 2013-2019 年间取自多家机构档案的 70 例细针穿刺细胞块中评估 NOR-1 抗体免疫组化表现,包括 10 例经典型低级别腺泡细胞癌、1 例去分化高级别腺泡细胞癌和 59 例非腺泡细胞癌。结果显示全部 11 例腺泡细胞癌均出现核阳性,而所有非腺泡细胞癌病例均无 NR4A3 表达,提示 NOR-1 可在细胞学标本上区分腺泡细胞癌与其类似病变。
要点
- NOR-1 在 11 例腺泡细胞癌细胞块中均呈核阳性,非腺泡细胞癌均阴性。
- 细胞块上 NOR-1 滴度需由 1:100 提高至 1:30 以完成优化。
- 当唾液腺肿瘤细胞学考虑腺泡细胞癌时,NOR-1 有助于与类似病变区分。
核心结论
- NOR-1 免疫组化在细针穿刺细胞块上可成功区分腺泡细胞癌与其细胞学类似病变。
研究设计与样本
- 研究纳入 2013-2019 年间多家机构档案的 70 例细针穿刺细胞块,含 10 例经典型低级别腺泡细胞癌、1 例去分化高级别腺泡细胞癌和 59 例非腺泡细胞癌。
- 采用 Bond-III(Leica)自动化免疫组化系统检测 NR4A3,使用 NOR-1 抗体(sc-393902 [H-7],Santa Cruz Biotechnology Inc.)。
- 细胞块抗体优化通过将滴度从 1:100(FFPE 标本建议滴度)提高至 1:30 完成。
主要发现
- 全部 11 例腺泡细胞癌均见明确核反应,其中 10 例为 3+ 弥漫核阳性、1 例为 2+ 局灶反应。
- 所有非腺泡细胞癌病例的细胞块中 NR4A3 表达均缺失。
关键数值与推荐
- 腺泡细胞癌 11 例均核阳性,非腺泡细胞癌 59 例均阴性。
- 细胞块 NOR-1 工作滴度为 1:30,高于 FFPE 建议的 1:100。
临床怎么用
- 对细针穿刺唾液腺肿瘤细胞学考虑腺泡细胞癌者,可加做 NOR-1 免疫组化以区分类似病变,并为早期肿瘤干预提供机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acinic cell carcinoma of the salivary gland (ACC-SG) is characterized by a recurrent chromosomal rearrangement (t(4; 9)(q13; q31)) that upregulates the transcription factor NR4A3. Studies conducted on formalin-fixed paraffin-embedded (FFPE) tissue have found that nuclear expression of a monoclonal antibody NR4A3 (NOR-1) is a sensitive and specific diagnostic marker for ACC-SG. The aims of this study were to evaluate the performance of the NOR-1 antibody and to compare its utility in separating ACC-SG from its mimics on cytology cell block specimens. Cell blocks were obtained from 70 fine-needle aspiration specimens from multiple institutional archives over a 7-year period (2013-2019). These included 10 cases of conventional low-grade ACC-SG, 1 case of dedifferentiated high-grade ACC-SG, and 59 cases of non-ACC-SG. An automated immunohistochemistry system (Bond-III, Leica) was used for the detection of NR4A3, using the commercially available antibody NOR-1 (sc-393902 [H-7], Santa Cruz Biotechnology Inc.). Optimization of the antibody on the cell blocks was successfully completed by increasing the titer from 1:100 (suggested titer for FFPE specimens) to 1:30. Distinct nuclear reactivity was observed in all 11 cases of ACC-SG (10 of 11 with 3+ diffuse nuclear positivity and 1 case with 2+ focal reactivity). Expression of NR4A3 was absent in all non-ACC-SG cases in the cell blocks. Application of the NOR-1 immunohistochemical staining in fine-needle aspirates of salivary gland tumors for which ACC-SG is a diagnostic consideration successfully distinguishes ACC-SG from its cytologic mimics and provides an early opportunity for oncologic intervention.
引用
- Nguyen L, Chopra S, Laskar DB, et al. NOR-1 distinguishes acinic cell carcinoma from its mimics on fine-needle aspiration biopsy specimens. Hum Pathol. 2020. PMID: 32416209. doi:10.1016/j.humpath.2020.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。